Processa Pharmaceuticals Inc (PCSA)
2.17
-0.09
(-3.98%)
USD |
NASDAQ |
May 03, 16:00
2.20
+0.03
(+1.38%)
After-Hours: 20:00
Processa Pharmaceuticals Free Cash Flow: -8.066M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.066M |
| September 30, 2023 | -8.440M |
| June 30, 2023 | -9.650M |
| March 31, 2023 | -9.916M |
| December 31, 2022 | -9.605M |
| September 30, 2022 | -9.835M |
| June 30, 2022 | -8.413M |
| March 31, 2022 | -8.277M |
| December 31, 2021 | -8.717M |
| September 30, 2021 | -8.266M |
| June 30, 2021 | -6.684M |
| March 31, 2021 | -4.840M |
| December 31, 2020 | -3.143M |
| September 30, 2020 | -1.481M |
| June 30, 2020 | -2.232M |
| March 31, 2020 | -2.689M |
| December 31, 2019 | -2.750M |
| September 30, 2019 | -2.601M |
| June 30, 2019 | -2.910M |
| March 31, 2019 | -3.267M |
| December 31, 2018 | -3.730M |
| September 30, 2018 | -4.671M |
| June 30, 2018 | -3.813M |
| Date | Value |
|---|---|
| March 31, 2018 | -2.724M |
| December 31, 2017 | -1.655M |
| September 30, 2017 | -0.257M |
| June 30, 2017 | -0.0665M |
| March 31, 2017 | 0.0056M |
| December 31, 2016 | -0.0432M |
| September 30, 2016 | -0.0823M |
| June 30, 2016 | -0.1462M |
| March 31, 2016 | -0.4202M |
| December 31, 2015 | -0.8733M |
| September 30, 2015 | -1.268M |
| June 30, 2015 | -1.771M |
| March 31, 2015 | -2.205M |
| December 31, 2014 | -2.703M |
| September 30, 2014 | -2.724M |
| June 30, 2014 | -2.904M |
| March 31, 2014 | -2.969M |
| December 31, 2013 | -2.566M |
| September 30, 2013 | -2.766M |
| June 30, 2013 | -2.937M |
| March 31, 2013 | -2.630M |
| December 31, 2012 | -1.892M |
Free Cash Flow Range, Past 5 Years
-9.916M
Minimum
Mar 2023
-1.481M
Maximum
Sep 2020
-6.238M
Average
-8.066M
Median
Dec 2023
Free Cash Flow Benchmarks
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.124M |
| Cash from Financing (Quarterly) | -0.0306M |
| Free Cash Flow Per Share (Quarterly) | -1.508 |
| Free Cash Flow Yield | -283.5% |